Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
40.12 EUR | +0.06% | +2.41% | -11.42% |
Apr. 10 | STRATEC BIOMEDICAL SYSTEMS AG : Warburg Research remains Neutral | ZD |
Apr. 08 | STRATEC BIOMEDICAL SYSTEMS AG : DZ Bank reiterates its Neutral rating | ZD |
Sales 2024 * | 276M 293M | Sales 2025 * | 297M 316M | Capitalization | 487M 519M |
---|---|---|---|---|---|
Net income 2024 * | 20M 21.29M | Net income 2025 * | 26M 27.68M | EV / Sales 2024 * | 2.18 x |
Net Debt 2024 * | 112M 120M | Net Debt 2025 * | 67.86M 72.24M | EV / Sales 2025 * | 1.87 x |
P/E ratio 2024 * |
23.9
x | P/E ratio 2025 * |
18.5
x | Employees | 1,480 |
Yield 2024 * |
2.17% | Yield 2025 * |
2.42% | Free-Float | 59.43% |
Latest transcript on Stratec SE
1 day | +0.06% | ||
1 week | +2.41% | ||
Current month | +0.37% | ||
1 month | -3.93% | ||
3 months | -2.77% | ||
6 months | +6.89% | ||
Current year | -11.42% |
Managers | Title | Age | Since |
---|---|---|---|
Marcus Wolfinger
CEO | Chief Executive Officer | 56 | 98-02-28 |
Robert Siegle
DFI | Director of Finance/CFO | 56 | 98-04-30 |
Jan Keppeler
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Frank Hiller
BRD | Director/Board Member | 57 | 19-05-28 |
Georg Heni
CHM | Chairman | 66 | 22-05-19 |
Rolf Vornhagen
BRD | Director/Board Member | 70 | 20-07-20 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.86% | 125 M€ | -.--% | ||
0.34% | 17 M€ | -.--% | - | |
0.01% | 773 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 40.35 | +0.62% | 26 |
24-04-22 | 40.1 | -0.12% | 3,839 |
24-04-19 | 40.15 | +0.25% | 5,382 |
24-04-18 | 40.05 | +2.82% | 10,946 |
24-04-17 | 38.95 | -1.14% | 6,990 |
Delayed Quote Xetra, April 23, 2024 at 03:00 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.42% | 519M | |
+3.31% | 209B | |
+2.05% | 175B | |
+9.36% | 131B | |
+17.66% | 99.98B | |
-2.09% | 61.12B | |
+14.05% | 52.34B | |
-4.15% | 46.5B | |
-3.68% | 39.24B | |
+9.04% | 38.47B |
- Stock Market
- Equities
- SBS Stock